A study evaluating the risk of overactive bladder as a side effect of cholinesterase inhibitor drugs taken for dementia and Alzheimer’s disease, finds that one drug — Donepezil — is linked to increased risk of the distressing side effect.
Risk of overactive bladder associated with medications for dementia
